NCT06929026View on ClinicalTrials.gov

Retinal Biomarkers in Parkinson´s Disease

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Parkinson Disease
Trial Locations (1)

101

Ophthalmic Outpatient Department Landspitali UH, Reykjavik

All Listed Sponsors
collaborator

Reykjalundur Rehabilitation

UNKNOWN

collaborator

University of Iceland

OTHER

lead

Landspitali University Hospital

OTHER

NCT06929026 - Retinal Biomarkers in Parkinson´s Disease | Biotech Hunter | Biotech Hunter